The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $118.76

Today's change+1.82 +1.56%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $118.76

Today's change+1.82 +1.56%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc up sharply

Abiomed Inc closed up sharply Friday, rallying (U.S.)$1.82 or 1.56% to (U.S.)$118.76. Shares have lost 2.20% over the last five days, but sit 4.78% below their 52-week high. This security has outperformed the S&P 500 by 10.29% during the last year.

Key company metrics

  • Open(U.S.) $117.28
  • Previous close(U.S.) $116.94
  • High(U.S.) $118.99
  • Low(U.S.) $116.36
  • Bid / Ask(U.S.) $95.00 / (U.S.) $0.00
  • YTD % change+31.55%
  • Volume262,123
  • Average volume (10-day)296,877
  • Average volume (1-month)461,496
  • Average volume (3-month)556,059
  • 52-week range(U.S.) $67.81 to (U.S.) $124.72
  • Beta0.89
  • Trailing P/E126.27×
  • P/E 1 year forward101.22×
  • Forward PEG3.68×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.94
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue103948676
Total other revenue--------
Total revenue103948676
Gross profit88797364
Total cost of revenue15151312
Total operating expense82746864
Selling / general / administrative51454240
Research & development16141412
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income21201713
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax21201713
Income after tax1311118
Income tax, total9975
Net income1311118
Total adjustments to net income--------
Net income before extra. items1311118
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1311118
Inc. avail. to common incl. extra. items1311118
Diluted net income1311118
Dilution adjustment0------
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.290.240.230.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.290.240.230.17